Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction-Reference-Cited by-同舟云学术

Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction

Published:2022-09-05 Issue:9 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

O'Byrne Lisa¹,Webster Katie E²,MacKeith Samuel³,Philpott Carl⁴,Hopkins Claire⁵,Burton Martin J⁶

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery; St Vincent’s University Hospital; Dublin 4 Ireland

2. Cochrane ENT; Nuffield Department of Surgical Sciences, University of Oxford; Oxford UK

3. Oxford University Hospitals NHS Foundation Trust; Oxford UK

4. Department of Medicine; Norwich Medical School, University of East Anglia; Norwich UK

5. ENT Department; Guy's Hospital; London UK

6. Cochrane UK; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference135 articles.

1. Randomized clinical trial "olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with palmitoylethanolamide and luteolin": preliminary results;D'Ascanio;European Review for Medical and Pharmacological Sciences,2021

2. Olfactory disfunction and Co-ultraPEALut https://clinicaltrials.gov/show/NCT04853836

3. Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients;Vaira;Rhinology,2021

4. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial;Abdelalim;American Journal of Otolaryngology,2021

5. Corticosteroid nasal spray in COVID-19 anosmia https://clinicaltrials.gov/show/NCT04484493

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Palmitoylethanolamide and Luteolin Association on Post-Covid Olfactory Dysfunction: A Systematic Review and Meta-Analysis of Clinical Studies;Biomedicines;2023-08-03

2. Post-viral olfactory loss and parosmia;BMJ Medicine;2023-07

3. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial;European Archives of Oto-Rhino-Laryngology;2023-06-28

4. Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out;Diseases;2023-05-27

5. Comparison of prevalence and evolution of COVID-19 olfactory disorders in patients infected by D614 (wild) and B.1.1.7. Alpha variant: a brief report;European Archives of Oto-Rhino-Laryngology;2023-03-21